We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

110 hedge funds and large institutions have $38.3M invested in Zomedica Corp. in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

3% more funds holding

Funds holding: 107 → 110 (+3)

1% more capital invested

Capital invested by funds: $37.8M → $38.3M (+$525K)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
110
Holders Change
+3
Holders Change %
+2.8%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
22
Reduced
22
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$404K
2
BlackRock
BlackRock
New York
+$232K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$136K
4
HF
HRT Financial
New York
+$89.5K
5
SCA
Snowden Capital Advisors
New York
+$58.9K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$3.28M
2
N
Nuveen
North Carolina
-$349K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$337K
4
UBS AM
UBS AM
Illinois
-$251K
5
CSS
Cubist Systematic Strategies
Connecticut
-$176K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
101
JP Morgan Chase
New York
$1K – – –
FF
102
FourThought Financial
Florida
$1K +$1.03K +3,150 New
KFS
103
Kelly Financial Services
Massachusetts
$506 – – –
APA
104
American Portfolios Advisors
New York
$84 – – –
N
105
Nuveen
North Carolina
– -$349K -1,060,731 Closed
CSS
106
Cubist Systematic Strategies
Connecticut
– -$176K -574,382 Closed
AGM
107
Alpine Global Management
New York
– -$122K -398,475 Closed
JAM
108
Jupiter Asset Management
United Kingdom
– -$61K -197,728 Closed
GSC
109
Ground Swell Capital
South Carolina
– -$54K -177,278 Closed
TI
110
Tidal Investments
Wisconsin
– -$51K -166,327 Closed
GIA
111
Gladstone Institutional Advisory
Florida
– -$17K -55,058 Closed
TRCT
112
Tower Research Capital (TRC)
New York
– -$9K -28,017 Closed
SG
113
StoneX Group
New York
– -$6.13K -20,000 Closed
KIG
114
Kessler Investment Group
Indiana
– -$5.18K -15,835 -98%
RJA
115
Raymond James & Associates
Florida
– -$4K -13,110 Closed
PFPT
116
Pinnacle Financial Partners (Tennessee)
Tennessee
– -$4K -12,500 Closed
Manulife (Manufacturers Life Insurance)
117
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$4 -11,482 Closed
PCMC
118
Paragon Capital Management (Colorado)
Colorado
– -$2K -6,700 Closed
HNB
119
Huntington National Bank
Ohio
– -$1K -4,000 Closed
Northwestern Mutual Wealth Management
120
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -2,200 Closed
SBL
121
Sargent Bickham Lagudis
Colorado
– -$1K -1,700 Closed
SWA
122
SOA Wealth Advisors
New York
– +$355 +1,084 New
1 2 3 4
5

ZOM Hedge Fund Activity: Q1 2022 in Review

110 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2022, worth a combined $38.3M — up 1.4% from $37.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ZOM positions and 18 closed out — a net gain of 4 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $404K. The largest seller was State Street, cutting an estimated $3.28M.

  • 110 institutional investors held Zomedica Corp. (ZOM) as of Q1 2022, up from 107 in Q4 2021.
  • Funds reported $38.3M of Zomedica Corp. stock for Q1 2022, up 1.4% quarter-over-quarter.
  • 22 funds opened new Zomedica Corp. positions in Q1 2022 and 18 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q1 2022 was Citadel Advisors, an estimated $404K added.
  • The largest Zomedica Corp. seller in Q1 2022 was State Street, an estimated $3.28M sold.

Based on aggregated 13F filings for Q1 2022.